Used in pharmaceutical research as a potent and selective inhibitor of the enzyme soluble epoxide hydrolase (sEH), this compound has shown promise in preclinical studies for treating inflammatory conditions, neuropathic pain, and cardiovascular diseases. Its ability to stabilize endogenous epoxy fatty acids contributes to anti-inflammatory and analgesic effects. Due to its favorable pharmacokinetic profile and blood-brain barrier penetration, it is also explored in neurological disorders such as multiple sclerosis and epilepsy. Commonly employed as a reference compound in sEH inhibition assays, it supports the development and validation of new therapeutic agents targeting the sEH pathway.